Facile and Straightforward Synthesis of Racemic Version of Substituted 3-[3-(2-Hydroxyphenyl)-3-oxo-1-arylpropyl]-4-hydroxycoumarins: Easy Access to a Series of Biorelevant Warfarin Analogues

Abstract

The present communication deals with a straightforward, efficient, and green synthesis of a series of racemic version of 3-[3-(2-hydroxyphenyl)-3-oxo-1-arylpropyl]-4-hydroxycoumarins as biologically interesting warfarin analogues upon decarboxylative hydrolysis of bis-coumarin derivatives in aqueous potassium hydroxide solution. The salient features of this practical method are operational simplicity, avoidance of any organic solvents and tedious column chromatographic purification, clean reaction profiles, excellent yields, and gram-scale synthetic applicability.

Keywords

3-[3-(2-hydroxyphenyl)-3-oxo-1-arylpropyl]-4-hydroxycoumarins - warfarin analogues - water medium - cost-effective - green synthesis

Publikationsverlauf

Eingereicht: 22. Juli 2021

Angenommen nach Revision: 30. August 2021

Accepted Manuscript online:
30. August 2021

Artikel online veröffentlicht:
06. Oktober 2021

• References

• 1a Chen X, Liu Y, Furukawa N, Jin D.-Y, Savage GP, Stafford DW, Suhara Y, Williams CM, Tie J.-K. J. Thromb. Haemost. 2021; 19: 689
• 1b Wardrop D, Keeling D. Br. J. Haematol. 2008; 141: 757
• 1c Fasco MJ, Principe LM, Walsh WA, Friedman PA. Biochemistry 1983; 22: 5655
• 1d Bell RG, Caldwell PT. Biochemistry 1973; 12: 1759
• 1e Bell RG, Sadowski JA, Matschiner JT. Biochemistry 1972; 11: 1959
• 2a Dong J, Du D.-M. Org. Biomol. Chem. 2012; 10: 8125
• 2b Park BK. Biochem. Pharmacol. 1988; 37: 19
• 3a Ndadza A, Thomford NE, Mukanganyama S, Wonkam A, Ntsekhe M, Dandara C. OMICS 2019; 23: 152
• 3b Hylek EM, Evans-Molina C, Shea C, HenaultL E, Regan S. Circulation 2007; 115: 2689
• 3c Elliott MJ, Zimmerman D, Holden RM. Am. J. Kidney Dis. 2007; 50: 433
• 3d Pirmohamed M. Br. J. Clin. Pharmacol. 2006; 62: 509
• 3e Delaney JA, Opatrny L, Suissa S. Br. J. Clin. Pharmacol. 2006; 61: 229
• 3f Boulanger L, Kim J, Friedman M, Hauch O, Foster T, Menzin J. Int. J. Clin. Pract. 2006; 60: 258
• 3g Newall F, Monagle P, Johnston L. Hematology 2005; 10: 437
• 3h Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar KB, Park K, Breckenridge AM. Br. Med. J. 2004; 329: 15
• 3i Linkins L.-A, Choi PT, Douketis JD. Ann. Intern. Med. 2003; 139: 893
• 3j Horton JD, Bushwick BM. Am. Fam. Physician 1999; 59: 635
• 4a Kwak JS, Bizarri N, Sharif S, Zhang WP, Mallik D, Organ MG. Chem. Eur. J. 2020; 26: 15505
• 4b Tomer SO, Soni HP. Catal. Sci. Technol. 2019; 9: 6517
• 4c Ibragimova DN, Fedotova OV, Ozerova AG, Koftin OV, Borodulin VB, Samokhvalov VA. Pharm. Chem. J. 2018; 51: 1053
• 4d Rogozińska M, Adamkiewicz A, Mlynarski J. Green Chem. 2011; 13: 1155
• 4e Kristensen TE, Vestli K, Hansen FK, Hansen T. Eur. J. Org. Chem. 2009; 5185
• 4f Kim H, Yen C, Preston P, Chin J. Org. Lett. 2006; 8: 5239
• 4g Halland N, Hansen T, Jørgensen KA. Angew. Chem. Int. Ed. 2003; 42: 4955
• 4h Robinson A, Li H.-Y. Tetrahedron Lett. 1996; 37: 8321
• 4i Demir AS, Tanyeli C, Gulbeyaz V. Turk. J. Chem. 1996; 20: 139
• 5a Kochetkov SV, Kucherenko AS, Zlotin SG. Org. Biomol. Chem. 2018; 16: 6423
• 5b Isik M, Akkoca HU, Akhmedov IM, Tanyeli C. Tetrahedron: Asymmetry 2016; 27: 384
• 5c Ska-Szymczak MR, Mlynarski J. Tetrahedron: Asymmetry 2014; 25: 813
• 5d Yang H.-M, Li L, Jiang K.-Z, Jiang J.-X, Lai G.-Q, Xu L.-W. Tetrahedron 2010; 66: 9708
• 5e Dong Z, Wang L, Chen X, Liu X, Lin L, Feng X. Eur. J. Org. Chem. 2009; 5192
• 6a Ursuegui S, Recher M, Krężel W, Wagner A. Nat. Commun. 2017; 8: 15242
• 6b Rosengren AM, Karlsson BC. G, Nicholls IA. ACS Med. Chem. Lett. 2012; 3: 650
• 6c Au N, Rettie AE. Drug Metab. Rev. 2008; 40: 355
• 6d Schalekamp T, Brassé BP, Roijers JF, Meegen ME. V, Meer FJ. M. V, Wijk DE. M.V, Egberts AC. G, Boer AD. Clin. Pharmacol. Ther. 2007; 81: 185
• 6e Schalekamp T, Brassé BP, Roijers JF. M, Chahid Y, Geest-Daalderop JH. H. V, Vries HD. G, Wijk EM. V, Egberts AC. G, Boer AD. Clin. Pharmacol. Ther. 2006; 80: 13
• 6f Schalekamp T, Oosterhof M, Meegen EV, Meer FJ. M. V. D, Conemans J, Hermans M, Meijerman I, Boer AD. Clin. Pharmacol. Ther. 2004; 76: 409
• 6g Schalekamp T, Geest-Daalderop JH. H. V, Vries HD.-G, Conemans J, Bernsen MJ, Boer AD. Clin. Pharmacol. Ther. 2004; 75: 394
• 6h Obaseki AO, Coker HB. J. Pharm. Pharmacol. 1987; 39: 142
• 7 Ikawa M, Stahmann MA, Link KP. J. Am. Chem. Soc. 1944; 66: 902
• 8 Talhi O, Fernandes JA, Pinto DC. G. A, Paz FA. A, Silva AM. S. J. Mol. Struct. 2015; 1094: 13
• 9a Brahmachari G, Bhowmick A, Karmakar I. J. Org. Chem. 2021; 86: 9658
• 9b Brahmachari G, Karmakar I, Karmakar P. Green Chem. 2021; 23: 4762
• 9c Brahmachari G, Karmakar I. J. Org. Chem. 2020; 85: 8851
• 9d Brahmachari G. Adv. Synth. Catal. 2020; 362: 5411
• 9e Brahmachari G, Nurjamal K. Tetrahedron Lett. 2019; 60: 1904
• 9f Brahmachari G, Mandal M, Karmakar I, Nurjamal K, Mandal B. ACS Sustainable Chem. Eng. 2019; 7: 6369
• 10 Khurana JM, Kumar S. Tetrahedron Lett. 2009; 50: 4125
• 11 CCDC 2070062 contains the supplementary crystallographic data for this paper. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/structures
• 12a Zhou Z.-Z, Yan G.-H, Chen W.-H, Yang X.-M. Chem. Pharm. Bull. 2013; 61: 1166
• 12b Godingan LA, West BD. J. Org. Chem. 1968; 33: 437
• 12c Stahmann MA, Huebner CF, Link KP. J. Biol. Chem. 1941; 138: 513
• 13a Brahmachari G, Begam S. ChemistrySelect 2019; 4: 5415
• 13b Seddighi M, Shirini F, Mamaghani M. RSC Adv. 2013; 3: 24046
• 13c Li M.-k, Li J, Liu B.-h, Zhou Y, Li X, Xue X.-y, Hou Z, Luo X.-x. Eur. J. Pharmacol. 2013; 751: 151
• 13d Padalkara V, Phatangarea K, Takaleb S, Pisalb R, Chaskar A. J. Saudi Chem. Soc. 2015; 19: 42
• 13e Nadaf AN, Shivashankar K. J. Heterocycl. Chem. 2018; 55: 1375
• 13f Sangshettia JN, Kokarea ND, Shindea DB. Green Chem. Lett. Rev. 2009; 2: 233